Catalyst Wire Dossier Catalyst Wire Dossier

Tapentadol ER

Tapentadol · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tapentadol ER, covering 2010-06-24 to 2018-01-25. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) [Phase 4]

See pricing